Evidence map›Paper›PMID 41958666›Full record

ArticleFrontiers in immunology2026

Case Report: Gitelman syndrome with a suspected MEFV- associated autoinflammatory phenotype: diagnostic challenges in a complex case.

Yu Li, Yun Lu, Yue Wang, Xiaotian Yang, Qiuchi Zhang, Yu Xie

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu LiNanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Yun LuNanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Yue WangNanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Xiaotian YangNanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Qiuchi ZhangDepartment of Neurology, First Affiliated Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Yu XieDepartment of Rheumatology and Immunology, First Affiliated Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of genetically confirmed Gitelman syndrome (GS) in a Chinese female patient presenting with systemic inflammatory manifestations and a heterozygous MEFV variant of uncertain significance. The patient initially exhibited arthritis, elevated inflammatory markers, and a positive labial gland biopsy, raising suspicion for Sjögren's syndrome. However, absence of sicca symptoms and failure to meet the 2016 ACR/EULAR classification criteria excluded a definitive diagnosis. Persistent hypokalemia, hypomagnesemia, and metabolic alkalosis led to genetic testing, which identified compound heterozygous pathogenic variants in SLC12A3, confirming GS. Although the MEFV variant suggested a possible autoinflammatory phenotype, established diagnostic criteria for familial Mediterranean fever were not fulfilled. This case highlights the diagnostic complexity arising from overlapping renal and inflammatory features and underscores the importance of cautious genetic interpretation and multidisciplinary evaluation in complex multisystem presentations.

Indexed as

Gitelman SyndromeMutationPyrinFemaleHumansMiddle AgedPhenotypeSolute Carrier Family 12, Member 3MEFV protein, humanPyrinSLC12A3 protein, humanSolute Carrier Family 12, Member 3autoinflammatory phenotypediagnostic challengesgenetic diagnosis actGitelman syndrome (GS)MEFV variant

Identifiers

PMID41958666
PMCPMC13057325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.